Search Within

Hannah Yong Wen

Formats
  1. Meeting Abstract (169)
  2. Journal Article (119)
  3. Review (18)
  4. Correspondence (1)
  5. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (308)
  2. GSK Faculty (174)
  3. Department of Medicine (141)
  4. Solid Tumor Oncology Division (141)
  5. Breast Medicine Service (139)
  6. Gynecology Disease Management Team (119)

More Groups

People
  1. Edi Brogi (203)
  2. Jorge Reis-Filho (128)
  3. Britta Weigelt (114)
  4. Fresia Pareja Zea (92)
  5. Larry Norton (83)
  6. Dara Ross (51)

More People

Years
  1. 2025 (21)
  2. 2024 (27)
  3. 2023 (21)
  4. 2022 (33)
  5. 2021 (19)
  6. 2020 (40)

More Years

Publications
  1. Laboratory Investigation (70)
  2. Modern Pathology (62)
  3. Cancer Research (23)
  4. Histopathology (14)
  5. npj Breast Cancer (14)
  6. Annals of Surgical Oncology (13)

More Publications

Publishers
  1. Nature Publishing Group (93)
  2. Nature Research (62)
  3. American Association for Cancer Research (29)
  4. Springer (28)
  5. Wiley Blackwell (27)
  6. Elsevier Inc. (17)

More Publishers

Results (308)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Discordance of human epidermal growth factor receptor 2-low status between breast primary and distant metastases with clinical–pathological correlation
    Journal Article

    Yang, E.; D'Alfonso, T. M.; Morrow, M.; Brogi, E.; Wen, H. Y.
    Histopathology (2025)

    Fulltext@MSK | Save
  • Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Chew, S. M.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D.; Modi, S.; Seidman, A. D.; Wen, H.; Brogi, E.; Robson, M.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Discordance of HER2-low status between breast primary and distant metastases with clinical-pathological correlation
    Meeting Abstract

    Yang, E.; D'Alfonso, T.; Brogi, E.; Wen, H.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • RB1 somatic alterations in ER-positive breast cancer: assessment of neuroendocrine differentiation
    Meeting Abstract

    Schwartz, C.; Marra, A.; Selenica, P.; da Silva, E. M.; Chandarlapaty, S.; Brogi, E.; Pareja, F.; Wen, H.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Variability in the diagnosis and reporting of metaplastic breast carcinoma: Results of a worldwide survey
    Meeting Abstract

    Wen, H.; Fineberg, S.; Mohamed, A.; Brogi, E.; Yang, E.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Validation of an artificial intelligence algorithm for the detection of special histologic subtypes of breast cancer and breast cancer grading
    Meeting Abstract

    Yang, E.; Retamero, J.; Brogi, E.; Klimstra, D.; Wen, H.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Assessment of HER2-low status in HER2-mutant breast carcinoma
    Meeting Abstract

    Yang, E.; Pareja, F.; Rana, S.; Brannon, A.; Vanderbilt, C.; Dikoglu, E.; Grabenstetter, A.; Wen, H.; Brogi, E.; Ross, D.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • RHOA genetic alterations and invasive lobular breast cancer
    Meeting Abstract

    Jalali Farahani, S.; Repetto, M.; Dopeso, H.; Gazzo, A.; Wen, H.; Brogi, E.; Ross, D.; Zhang, H.; Weigelt, B.; Pareja, F.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Oncotype DX recurrence score in node positive patients in the post-RxPONDER era: A single institution experience
    Meeting Abstract

    Han, R.; Brogi, E.; El-Tamer, M.; Morrow, M.; Wen, H.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Quantification of ER, PR, and Ki67 in breast cancer using image analysis software: A validation study
    Meeting Abstract

    Han, R.; Wen, H.; Giri, D.; Kuba, M.; Hanna, M.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save